Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

DNA Vaccines - A Modern Gimmick or a Boon to Vaccinology?

Manickan E, Karem KL, Rouse BT.

Crit Rev Immunol. 2017;37(2-6):483-498. doi: 10.1615/CritRevImmunol.v37.i2-6.140. Review.

PMID:
29773031
2.

Rapid Kupffer cell death after intravenous injection of adenovirus vectors.

Manickan E, Smith JS, Tian J, Eggerman TL, Lozier JN, Muller J, Byrnes AP.

Mol Ther. 2006 Jan;13(1):108-17. Epub 2005 Sep 28.

3.
4.

Conditional liver-specific expression of simian virus 40 T antigen leads to regulatable development of hepatic neoplasm in transgenic mice.

Manickan E, Satoi J, Wang TC, Liang TJ.

J Biol Chem. 2001 Apr 27;276(17):13989-94. Epub 2001 Jan 18. Erratum in: J Biol Chem 2002 Jan 4;277(1):869.

5.

Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10.

Manickan E, Daheshia M, Kuklin N, Chun S, Rouse BT.

Immunology. 1998 Jun;94(2):129-34.

6.

Protection by minigenes: a novel approach of DNA vaccines.

Yu Z, Karem KL, Kanangat S, Manickan E, Rouse BT.

Vaccine. 1998 Oct;16(17):1660-7.

PMID:
9713944
7.

Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines.

Daheshia M, Kuklin N, Manickan E, Chun S, Rouse BT.

Vaccine. 1998 Jul;16(11-12):1103-10.

PMID:
9682365
8.

DNA vaccines and immunity to herpes simplex virus.

Rouse BT, Nair S, Rouse RJ, Yu Z, Kuklin N, Karem K, Manickan E.

Curr Top Microbiol Immunol. 1998;226:69-78. Review. No abstract available.

PMID:
9479836
9.

Control of herpetic stromal keratitis using CTLA4Ig fusion protein.

Gangappa S, Manickan E, Rouse BT.

Clin Immunol Immunopathol. 1998 Jan;86(1):88-94.

PMID:
9434800
10.

DNA immunization of neonates induces immunity despite the presence of maternal antibody.

Manickan E, Yu Z, Rouse BT.

J Clin Invest. 1997 Nov 1;100(9):2371-5.

11.

Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10.

Daheshia M, Kuklin N, Kanangat S, Manickan E, Rouse BT.

J Immunol. 1997 Aug 15;159(4):1945-52.

PMID:
9257860
12.

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT.

J Virol. 1997 Apr;71(4):3138-45.

13.

Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells.

Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT.

J Leukoc Biol. 1997 Feb;61(2):125-32.

PMID:
9021916
14.

DNA vaccines -- a modern gimmick or a boon to vaccinology?

Manickan E, Karem KL, Rouse BT.

Crit Rev Immunol. 1997;17(2):139-54. Review.

PMID:
9094450
15.

Role of interferon-gamma in immunity to herpes simplex virus.

Yu Z, Manickan E, Rouse BT.

J Leukoc Biol. 1996 Oct;60(4):528-32.

PMID:
8864138
17.

Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells.

Manickan E, Francotte M, Kuklin N, Dewerchin M, Molitor C, Gheysen D, Slaoui M, Rouse BT.

J Virol. 1995 Aug;69(8):4711-6.

18.

Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.

Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT.

J Immunol. 1995 Jul 1;155(1):259-65.

PMID:
7602102
19.

Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.

Manickan E, Yu Z, Rouse RJ, Wire WS, Rouse BT.

Viral Immunol. 1995;8(2):53-61.

PMID:
8825290

Supplemental Content

Loading ...
Support Center